Pipethiaden is a benzothiepin-based drug candidate that was at one time studied as a potential preventive to reduce the frequency of recurrent migraine headaches. It also has some activity as an antihistamine acting mainly at the 5-HT2A and 5HT2C receptors.[2]

Pipethiaden
Clinical data
ATC code
  • None
Identifiers
  • 1-Methyl-4-(thieno[2,3-c][2]benzothiepin-4(9H)-ylidene)piperidine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H19NS2
Molar mass313.48 g·mol−1
3D model (JSmol)
  • CN1CCC(=C2c3ccccc3CSc4c2ccs4)CC1
  • InChI=InChI=1S/C18H19NS2/c1-19-9-6-13(7-10-19)17-15-5-3-2-4-14(15)12-21-18-16(17)8-11-20-18/h2-5,8,11H,6-7,9-10,12H2,1H3
  • Key:VZWWTHTUQTYAGH-UHFFFAOYSA-N[1]

References

edit
  1. ^ "1-Methyl-4-(thieno[2,3-c][2]benzothiepin-4(9H)-ylidene)piperidine".
  2. ^ Frycová H, Metys J (July 1989). "[Anti-allergic properties of pipethiaden--a new preventive agent for migraine]". Ceskoslovenska Farmacie (in Czech). 38 (6): 264–8. PMID 2790993.